Subscribe
shutterstock_384310168_doro_guzenda
Doro Guzenda / Shutterstock.com
19 April 2022MedtechFran Salisbury and Alice Jefferies

Predicting the unpredictable during pregnancy

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More features

Apple wins just $250 in Masimo smartwatch clash
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
How to navigate patent term adjustment in China
‘I’m breaking new ground’: Mölnlycke’s first TM attorney charts a new course
Preventative IP for preventative pharma healthcare
Dexcom suffers second patent revocation at hands of UPC
Does the UPC offer a fresh take on patent validity?
Litigation implications of the USPTO’s terminal disclaimer proposal